檢索結果 - Elisabeth I. Heath

Refine Results
  1. 1
    Angiogenesis inhibitors in the treatment of prostate cancer

    Angiogenesis inhibitors in the treatment of prostate cancer 由 Clara Hwang, Elisabeth I. Heath

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Prostate cancer dormancy and recurrence

    Prostate cancer dormancy and recurrence 由 Frank C. Cackowski, Elisabeth I. Heath

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes

    Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes 由 Dejuan Kong, Seema Sethi, Yiwei Li, Wei Chen, Wael Sakr, Elisabeth I. Heath, Fazlul H. Sarkar

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinum Refractory Non-small Cell Lung Cancer (NSCLC)

    Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinu... 由 Shirish M. Gadgeel, John C. Ruckdeschel, Elisabeth I. Heath, Lance K. Heilbrun, Raghu Venkatramanamoorthy, Antoinette J. Wozniak

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer

    Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer 由 Lauren M. Hamel, Louis A. Penner, Terrance L. Albrecht, Elisabeth I. Heath, Clement K. Gwede, Susan Eggly

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Galectin-3: a possible complementary marker to the PSA blood test

    Galectin-3: a possible complementary marker to the PSA blood test 由 Vitaly Balan, Yi Wang, Pratima Nangia‐Makker, Dhonghyo Kho, Madhuri Bajaj, Daryn Smith, Lance K. Heilbrun, Avraham Raz, Elisabeth I. Heath

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

    Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis 由 M. Katie Conley‐LaComb, Louie Semaan, Rajareddy Singareddy, Yanfeng Li, Elisabeth I. Heath, Seongho Kim, Michael L. Cher, Sreenivasa R. Chinni

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial

    Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial 由 Przemyslaw Twardowski, Walter M. Stadler, Paul Frankel, Primo N. Lara, Christopher Ruel, Gurkamal Chatta, Elisabeth I. Heath, David I. Quinn, David R. Gandara

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients

    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients 由 Amitabh Chak, Marcia I. Canto, Gregory S. Cooper, Gerard Isenberg, Joseph Willis, Nathan Levitan, Julie Clayman, Arlene A. Forastiere, Elisabeth I. Heath, Michael Sivak

    出版 2000
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

    Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy 由 Ghayathri Jeyakumar, Seongho Kim, Naresh Bumma, Craig Landry, Cynthia Silski, Stacey Suisham, Brenda Dickow, Elisabeth I. Heath, Joseph A. Fontana, Ulka N. Vaishampayan

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Prostate Tumor Cell–Derived IL1β Induces an Inflammatory Phenotype in Bone Marrow Adipocytes and Reduces Sensitivity to Docetaxel via Lipolysis-Dependent Mechanisms

    Prostate Tumor Cell–Derived IL1β Induces an Inflammatory Phenotype in Bone Marrow Adipocytes and Reduces Sensitivity to Docetaxel via Lipolysis-Dependent Mechanisms 由 Mackenzie K. Herroon, Jonathan D. Diedrich, Erandi Rajagurubandara, Carly Martin, Krishna Rao Maddipati, Seongho Kim, Elisabeth I. Heath, James G. Granneman, Izabela Podgorski

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Smartphone apps for cancer: A content analysis of the digital health marketplace

    Smartphone apps for cancer: A content analysis of the digital health marketplace 由 Deborah H. Charbonneau, Shonee Hightower, Anne Katz, Ke Zhang, Judith Abrams, Nicole Senft, Jennifer Beebe‐Dimmer, Elisabeth I. Heath, Tara Eaton, Hayley S. Thompson

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Racial Disparities in the Molecular Landscape of Cancer

    Racial Disparities in the Molecular Landscape of Cancer 由 Elisabeth I. Heath, Filipa Lynce, Joanne Xiu, Angela Ellerbrock, Sandeep K. Reddy, Elias Obeid, Stephen V. Liu, Aliccia Bollig‐Fischer, Duška Šeparović, Ari M. Vanderwalde

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

    A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802 由 Naomi B. Haas, Xinyi Lin, Judith Manola, Michael Pins, Glenn Liu, David F. McDermott, David M. Nanus, Elisabeth I. Heath, George Wilding, Janice P. Dutcher

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Soy Isoflavones in Conjunction With Radiation Therapy in Patients With Prostate Cancer

    Soy Isoflavones in Conjunction With Radiation Therapy in Patients With Prostate Cancer 由 Iftekhar Ahmad, Jeffrey D. Forman, Fazlul H. Sarkar, Gilda G. Hillman, Elisabeth I. Heath, Ulka N. Vaishampayan, Michael L. Cher, Fundagül Andiç, Peter J. Rossi, Ömer Küçük

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study

    A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate canc... 由 Manish Thakur, Lance K. Heilbrun, Shijie Sheng, Mark N. Stein, Glenn Liu, Emmanuel S. Antonarakis, Ulka N. Vaishampayan, Sijana H. Dzinic, Xiaohua Li, Stacy Freeman, Daryn Smith, Elisabeth I. Heath

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer

    Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer 由 Anthony V. Serritella, Daniel H. Shevrin, Elisabeth I. Heath, James L. Wade, Elia Martinez, Amanda Anderson, Joseph D. Schonhoft, Yen-Lin Chu, Theodore Karrison, Walter M. Stadler, Russell Z. Szmulewitz

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Secondary Chemoprevention of Barrett's Esophagus With Celecoxib: Results of a Randomized Trial

    Secondary Chemoprevention of Barrett's Esophagus With Celecoxib: Results of a Randomized Trial 由 Elisabeth I. Heath, Marcia I. Canto, Steven Piantadosi, Elizabeth A. Montgomery, W.M. Weinstein, James G. Herman, Andrew J. Dannenberg, Vincent W. Yang, Albert O. Shar, Ernest T. Hawk, Arlene A. Forastiere

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors

    Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors 由 Patricia LoRusso, Martin J. Edelman, S. Bever, Karen Forman, MaryJo Pilat, Mary Flanagan Quinn, Jing Li, Elisabeth I. Heath, Lisa Malburg, Patrick Klein, Christopher P. Leamon, Richard A. Messmann, Edward A. Sausville

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    The current state of molecular testing in the treatment of patients with solid tumors, 2019

    The current state of molecular testing in the treatment of patients with solid tumors, 2019 由 Wafik S. El‐Deiry, Richard M. Goldberg, Heinz‐Josef Lenz, Anthony F. Shields, Geoffrey T. Gibney, Antoinette R. Tan, Jubilee Brown, Burton Eisenberg, Elisabeth I. Heath, Surasak Phuphanich, Edward Kim, Andrew Brenner, John L. Marshall

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: